Close Menu

And ... Recruited

Randy Schekman will be the first editor of the new open-access journal being formed by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust, according to a news release from HHMI. Schekman is a cell biologist and the current editor-in-chief of the Proceedings of the National Academy of Sciences. According to HHMI, he will begin working on the new journal in August, dedicating half of his time to that project while also helping PNAS find his successor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.